ABBOTT LABORATORIES — Director's Dealing 2009

Feb 24, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-02-20

Reporting Person: Landgraf John C (Senior Voce President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-02-20	Common shares without par value	A	27200	—	Acquired	125608	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-02-20	Option (right to buy)	$54.14	A	38700	Acquired	2019-02-19	Common Shares (38700)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	15990	Indirect
Common shares without par value	30000	Indirect
Common shares without par value	1598	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 19, 2009.

F3: Held in the Ann Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees. The trust is revocable by his spouse.

F4: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F5: The reporting person disclaims beneficial ownership of all securities held by his son.

F6: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,900 on 02/20/2010, 12,900 on 02/20/2011, and 12,900 on 02/20/2012.